162 related articles for article (PubMed ID: 36004775)
1. Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity.
Wang L; Li C; Wang J; Yang G; Lv Y; Fu B; Jian L; Ma J; Yu J; Yang Z; Wu P; Li G; Liu X; Kang Z; Wang Z; Wang L; Wang H; Xu W
Adv Mater; 2022 Oct; 34(43):e2203518. PubMed ID: 36004775
[TBL] [Abstract][Full Text] [Related]
2. FAK-independent alphavbeta3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts.
Zoppi N; Barlati S; Colombi M
Biochim Biophys Acta; 2008 Jun; 1783(6):1177-88. PubMed ID: 18405669
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase.
Zhang Y; Lu H; Dazin P; Kapila Y
J Biol Chem; 2004 Nov; 279(46):48342-9. PubMed ID: 15331608
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M
Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447
[TBL] [Abstract][Full Text] [Related]
5. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
Zoppi N; Ritelli M; Colombi M
Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin regulates anoikis resistance via cell aggregate formation.
Han HJ; Sung JY; Kim SH; Yun UJ; Kim H; Jang EJ; Yoo HE; Hong EK; Goh SH; Moon A; Lee JS; Ye SK; Shim J; Kim YN
Cancer Lett; 2021 Jun; 508():59-72. PubMed ID: 33771684
[TBL] [Abstract][Full Text] [Related]
7. PKM2 allosteric converter: A self-assembly peptide for suppressing renal cell carcinoma and sensitizing chemotherapy.
Wang L; Fu B; Hou DY; Lv YL; Yang G; Li C; Shen JC; Kong B; Zheng LB; Qiu Y; Wang HL; Liu C; Zhang JJ; Bai SY; Li LL; Wang H; Xu WH
Biomaterials; 2023 May; 296():122060. PubMed ID: 36934477
[TBL] [Abstract][Full Text] [Related]
8. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
Kamarajan P; Kapila YL
Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
[TBL] [Abstract][Full Text] [Related]
9. Harnessing Focal Adhesions to Accelerate p53 Accumulation and Anoikis of A549 Cells Using Colloidal Self-Assembled Patterns (cSAPs).
Enkhbat M; Zhong B; Chang R; Geng J; Lu LS; Chen YJ; Wang PY
ACS Appl Bio Mater; 2022 Jan; 5(1):322-333. PubMed ID: 35034455
[TBL] [Abstract][Full Text] [Related]
10. Antiadhesive sites present in the fibronectin type III-like repeats of human plasma fibronectin.
Miura S; Kamiya S; Saito Y; Wada S; Hayashi R; Taira J; Kodama H; Yajima H; Ueki M; Fukai F
Biol Pharm Bull; 2007 May; 30(5):891-7. PubMed ID: 17473431
[TBL] [Abstract][Full Text] [Related]
11. Targeting anoikis resistance in prostate cancer metastasis.
Sakamoto S; Kyprianou N
Mol Aspects Med; 2010 Apr; 31(2):205-14. PubMed ID: 20153362
[TBL] [Abstract][Full Text] [Related]
12. ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
Malin D; Strekalova E; Petrovic V; Rajanala H; Sharma B; Ugolkov A; Gradishar WJ; Cryns VL
Oncogene; 2015 Nov; 34(45):5626-34. PubMed ID: 25684139
[TBL] [Abstract][Full Text] [Related]
13. Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer.
Dong B; Gu Y; Sun X; Wang X; Zhou Y; Rong Z; Zhang J; Shi X; Zhang Z; He X; Chen L; Xiong Q; Pang X; Cui Y
Adv Healthc Mater; 2024 May; ():e2400673. PubMed ID: 38809199
[TBL] [Abstract][Full Text] [Related]
14. HIFα independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl
Magdaleno C; Dixon L; Rajasekaran N; Varadaraj A
Sci Rep; 2020 Oct; 10(1):18560. PubMed ID: 33122751
[TBL] [Abstract][Full Text] [Related]
15. Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.
Sakamoto S; Schwarze S; Kyprianou N
Eur Urol; 2011 May; 59(5):734-44. PubMed ID: 21269758
[TBL] [Abstract][Full Text] [Related]
16. Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis.
Yu M; Lu B; Liu Y; Me Y; Wang L; Li H
Mol Med Rep; 2017 Mar; 15(3):1103-1108. PubMed ID: 28112366
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents.
Díaz-Montero CM; McIntyre BW
BMC Cancer; 2005 Apr; 5():39. PubMed ID: 15829011
[TBL] [Abstract][Full Text] [Related]
18. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).
Hazlehurst LA; Damiano JS; Buyuksal I; Pledger WJ; Dalton WS
Oncogene; 2000 Sep; 19(38):4319-27. PubMed ID: 10980607
[TBL] [Abstract][Full Text] [Related]
19. Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.
Oudin MJ; Jonas O; Kosciuk T; Broye LC; Guido BC; Wyckoff J; Riquelme D; Lamar JM; Asokan SB; Whittaker C; Ma D; Langer R; Cima MJ; Wisinski KB; Hynes RO; Lauffenburger DA; Keely PJ; Bear JE; Gertler FB
Cancer Discov; 2016 May; 6(5):516-31. PubMed ID: 26811325
[TBL] [Abstract][Full Text] [Related]
20. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]